Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine

Autor: Döhner, Hartmut, Wei, Andrew H., Roboz, Gail J., Montesinos, Pau, Thol, Felicitas R., Ravandi, Farhad, Dombret, Hervé, Porkka, Kimmo, Sandhu, Irwindeep, Skikne, Barry, See, Wendy L., Ugidos, Manuel, Risueño, Alberto, Chan, Esther T., Thakurta, Anjan, Beach, C.L., Lopes de Menezes, Daniel
Zdroj: In Blood 13 October 2022 140(15):1674-1685
Databáze: ScienceDirect